The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
A new flu vaccine using messenger RNA technology is available at some King Soopers pharmacies in Colorado, offering adults 50 ...
The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach ...
A combination of the personalized cancer vaccine intismeran autogene and Merck's Keytruda just barely cleared analysts’ ...
A New Zealand agency has invested in a US startup developing a vaccine to reduce livestock methane emissions, but the jab does not use mRNA, contrary to conspiratorial posts online reviving Covid-era ...
1don MSN
Doctors call Moderna, Merck's cancer vaccine data a major advancement — even as stocks fall
Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma ...
Until now, the flu shot lineup featured six vaccination options —using live viruses, inactivated viruses or viral antigens—delivered via needle injection or nasal spray. The mRNA vaccine has proven ...
The data marks a fundamental turning point in the prevention of melanoma recurrences, a disease where avoiding relapse and ...
The Tumaini Ebola vaccine trial in Congo began in Bunia on 23 October 2026, testing Ervebo against the Bundibugyo strain amid ...
WREG-TV Memphis on MSN
‘Now is the time’: 2026 flu shot expected to provide better protection
MEMPHIS, Tenn. — Early season flu activity has kicked in here in the Mid-South. That’s according to two infectious disease specialists we spoke with this week. The good news is this year’s shot will ...
Discover the top stories from Oct. 17 to Oct. 23, 2026, including why thousands of snakes close a road in Illinois twice a ...
Moderna fell up to 25% despite a cancer vaccine that cut melanoma recurrence or death risk 42%, as expectations ran high.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results